Retraction Note: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations

Affiliations

• ¹ Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
• ² Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA.
• ³ Department of Genetics, Institute of Ophthalmology, NIHR Biomedical Research Centre, University College London, London, UK.
• ⁴ Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA, USA. tli@meei.harvard.edu.